South Dakota Investment Council’s Corcept Therapeutics CORT Stock Holding History

South Dakota Investment Council’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-275	Closed	-$5K	–	590
2021 Q3	$5K	Sell	275 -15,700	-98%	-$329K	﹤0.01%	585
2021 Q2	$351K	Sell	15,975 -15,600	-49%	-$347K	0.01%	552
2021 Q1	$751K	Buy	31,575 +275	+0.9%	+$7.34K	0.01%	511
2020 Q4	$819K	Hold	31,300	–	–	0.02%	472
2020 Q3	$545K	Sell	31,300 -14,700	-32%	-$234K	0.01%	493
2020 Q2	$774K	Sell	46,000 -7,400	-14%	-$104K	0.02%	432
2020 Q1	$635K	Hold	53,400	–	–	0.02%	419
2019 Q4	$646K	Hold	53,400	–	–	0.01%	464
2019 Q3	$755K	Buy	53,400 +8,800	+20%	+$108K	0.01%	487
2019 Q2	$497K	Hold	44,600	–	–	0.01%	508
2019 Q1	$524K	Hold	44,600	–	–	0.01%	495
2018 Q4	$596K	Hold	44,600	–	–	0.02%	453
2018 Q3	$625K	Buy	+44,600	New	+$623K	0.01%	488

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

South Dakota Investment Council's CORT Position: Q4 2021 in Review

South Dakota Investment Council sold out of Corcept Therapeutics (CORT) in Q4 2021, closing a stake of 275 shares — an estimated $5K sold.

South Dakota Investment Council first reported a position in CORT in Q3 2018 and held it in 13 quarters. The position peaked at $819K in Q4 2020. 208 funds tracked by Wall St. Rank hold CORT as of Q4 2021.

South Dakota Investment Council reported no remaining Corcept Therapeutics position as of Q4 2021 after selling out during the quarter.
South Dakota Investment Council sold 275 Corcept Therapeutics shares in Q4 2021, an estimated $5K.
South Dakota Investment Council first reported a position in Corcept Therapeutics in Q3 2018 and held it in 13 quarters.
South Dakota Investment Council's Corcept Therapeutics position peaked at $819K in Q4 2020.
208 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2021.

Based on South Dakota Investment Council's 13F filing for Q4 2021, filed 8 Feb 2022.